Aquestive Therapeutics, Inc. ( (AQST) ) has released its Q3 earnings. Here is a breakdown of the information Aquestive Therapeutics, Inc. presented to its investors.
Claim 55% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
Aquestive Therapeutics, Inc. is a pharmaceutical company focused on developing innovative medicines using advanced delivery technologies to improve patient outcomes, particularly in the field of orally administered therapies for complex molecules. The company is actively working on expanding its product pipeline and commercializing its proprietary products.